A new role for P2X4 receptors as modulators of lung surfactant secretion by Miklavc, Pika et al.
“fncel-07-00171” — 2013/10/4 — 18:41 — page 1 — #1
MINI REVIEW ARTICLE
published: 08 October 2013
doi: 10.3389/fncel.2013.00171
A new role for P2X4 receptors as modulators of lung
surfactant secretion
Pika Miklavc, Kristin E.Thompson and Manfred Frick*
Institute of General Physiology, University of Ulm, Ulm, Germany
Edited by:
Geoffrey Burnstock, University
College Medical School, UK
Reviewed by:
Jean-Pierre Timmermans, University
of Antwerp (State University Centre
Antwerp), Belgium
Ruth Dorothy Murrell-Lagnado,
University of Cambridge, UK
*Correspondence:
Manfred Frick, Institute of General
Physiology, University of Ulm,
Albert-Einstein Allee 11, 89081 Ulm,
Germany
e-mail: manfred.frick@uni-ulm.de
In recent years, P2X receptors have attracted increasing attention as regulators of
exocytosis and cellular secretion. In various cell types, P2X receptors have been found
to stimulate vesicle exocytosis directly via Ca2+ inﬂux and elevation of the intracellular
Ca2+ concentration. Recently, a new role for P2X4 receptors as regulators of secretion
emerged. Exocytosis of lamellar bodies (LBs), large storage organelles for lung surfactant,
results in a local, fusion-activated Ca2+ entry (FACE) in alveolar type II epithelial cells.
FACE is mediated via P2X4 receptors that are located on the limiting membrane of LBs
and inserted into the plasma membrane upon exocytosis of LBs. The localized Ca2+ inﬂux
at the site of vesicle fusion promotes fusion pore expansion and facilitates surfactant
release. In addition, this inward-rectifying cation current across P2X4 receptors mediates
ﬂuid resorption from lung alveoli. It is hypothesized that the concomitant reduction in the
alveolar lining ﬂuid facilitates insertion of surfactant into the air–liquid interphase thereby
“activating” it.These ﬁndings constitute a novel role for P2X4 receptors in regulating vesicle
content secretion as modulators of the secretory output during the exocytic post-fusion
phase.
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INTRODUCTION
In recent years, P2X receptors have attracted increasing atten-
tion as regulators of exocytosis and cellular secretion in a wide
variety of organs including the lungs (Burnstock et al., 2012).
P2X receptors are membrane cation channels that are activated
by extracellular adenosine triphosphate (ATP), the molecular
and functional properties of which have been reviewed in detail
elsewhere (Surprenant, 1996; North, 2002; Khakh and North,
2006; Burnstock and Kennedy, 2011; Kaczmarek-Hajek et al.,
2012). ATP has been known to stimulate cellular secretion
for several decades (Rodriguez Candela and Garcia-Fernandez,
1963; Diamant and Kruger, 1967). One of the earliest indica-
tions for involvement of P2X receptors in stimulating secretion
came from the studies of Cockcroft and Gomperts (1979a,b,
1980). They found that ATP triggers degranulation and his-
tamine release in mast cells via activation of P2Z (Cockcroft
and Gomperts, 1980), which later turned out to be P2X7
(Surprenant et al., 1996). Since the ﬁrst cloning of P2X receptor
subunits in 1994 (Brake et al., 1994; Valera et al., 1994), P2X recep-
tors have been found to stimulate and modulate various cellular
secretion pathways, including ﬂuid secretion in exocrine glands
and epithelia (Novak, 2011), secretion of cytokines via release
of plasma-derived microvesicles (Solini et al., 1999; MacKen-
zie et al., 2001) or exosomes (Qu et al., 2007; Qu and Dubyak,
2009).
Moreover, several members of the P2X family have been impli-
cated in regulating exocytosis of secretory organelles in a variety
of cell types (Gu and MacDermott, 1997; Ulmann et al., 2008;
Jacques-Silva et al., 2010; Gutierrez-Martin et al., 2011; Huang
et al., 2011). Substantial evidence suggests that P2X receptor acti-
vation stimulates exocytosis directly via inﬂux of Ca2+ from
the extracellular space and elevation of the cytoplasmic Ca2+
concentration ([Ca2+]c; Kim et al., 2004; Shigetomi and Kato,
2004; Jacques-Silva et al., 2010; Hayoz et al., 2012). It is well
established that a series of Ca2+-dependent steps during the
exocytic pre-fusion stage is essential for fusion of exocytic vesi-
cles with the plasma membrane (Burgoyne and Morgan, 1998;
Sudhof, 2004; Neher and Sakaba, 2008). Ca2+ can either enter
through P2X receptor pores themselves or through voltage-gated
Ca2+ channels, which are activated as a consequence of the P2X
receptor-mediated membrane depolarization (Khakh and North,
2006). In line with these ﬁndings, several studies proposed a role
for P2X4 receptors in exocytosis that is mediated via an increase in
the intracellular Ca2+ concentration. P2X4 receptors have a rela-
tively slow desensitization (5–10 s) and a high Ca2+ permeability,
Ca2+ contributes 8% of the whole current in human P2X4 (Wang
et al., 1996; Garcia-Guzman et al., 1997; North, 2002; Egan and
Khakh, 2004). Hence, activation of P2X4 receptors can generate
sufﬁcient increases in [Ca2+]c to stimulate regulated exocyto-
sis. Indeed, insulin secretion from pancreatic islets (Ohtani et al.,
2011) and exocytic response in parotid acinar cells (Bhattacharya
et al., 2012) following stimulation with ATP were augmented in
the presence of ivermectin, a selective potentiator of P2X4 recep-
tor currents (Khakh et al., 1999). P2X4 activation was also found
to modulate glutamate and gamma-aminobutyric acid (GABA)
release in hypothalamic neurons (Vavra et al., 2011) and brain-
derived neurotrophic factor (BDNF) in microglial cells (Trang
et al., 2009).
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FIGURE 1 | P2X4 receptors on LBs modulate surfactant secretion.
P2X4 receptors are expressed on LBs, large storage organelles for
pulmonary surfactant in ATII cells (1). Upon exocytosis of LBs, P2X4
receptors readily become part of the apical membrane and activation of
P2X4 by extracellular ATP results in a transient, non-selective, inward-
rectifying, cation current at the site of the fused vesicle causing a local
increase in Ca2+ around the fused vesicle (2). The local increase in
Ca2+ promotes fusion pore expansion (3a). In addition, the inward-
rectifying cation current on the apical side results in vectorial ion trans-
port across ATII cells, which in turn promotes ﬂuid resorption and
thereby facilitates adsorption of newly released surfactant into the
air–liquid interface (3b). ASL = alveolar surface liquid.
In all of these systems, activation of P2X receptors adjusts the
secretory output predominantly by modulating the number of
vesicles that fuse with the plasma membrane. Depending on the
cell type and the shape of the Ca2+ signal, the rise in [Ca2+]c
triggers fusion of secretory vesicles with the plasma membrane,
but also affects maturation and trafﬁcking of secretory vesicles to
the plasma membrane (Neher and Sakaba, 2008; Dolensek et al.,
2011; Gutierrez-Martin et al., 2011).
VESICULAR P2X4 RECEPTORS PROMOTE SURFACTANT
SECRETION VIA FACE – “FUSION-ACTIVATED Ca2+-ENTRY”
Apart from regulating secretion via adjusting the number of fusing
organelles the amount and composition of the secretory output
is – at least for exocytosis of large secretory granules and secre-
tion of bulky vesicle contents – modulated following fusion of the
vesicle with the plasma membrane during the so-called exocytic
“post-fusion” phase. Recent evidence also suggests a role for P2X4
receptors therein. It has been demonstrated that activation of P2X4
receptors following vesicle–plasma membrane fusion modulates
the secretion and activation of pulmonary surfactant (Miklavc
et al., 2011; Dietl et al., 2012; Thompson et al., 2013).
Pulmonary surfactant is secreted via exocytosis of lamellar
bodies (LBs), large lysosome-related storage organelles in alve-
olar type II (ATII) epithelial cells. Surfactant is stored in LBs as
densely packedmembranous structures that do not readily diffuse
out of fused LBs following opening of the exocytic fusion pore.
Rather, surfactant is so insoluble, that it may remain entrapped
within the fused vesicle for many minutes and the slowly expand-
ing fusion pore acts as a mechanical barrier for the release (Dietl
et al., 2001; Haller et al., 2001; Singer et al., 2003; Dietl and Haller,
2005; Miklavc et al., 2012).
Miklavc et al. (2010) initially discovered that exocytosis of LBs
results in localized Ca2+ inﬂux at the site of vesicle fusion which
they termed “FACE” for “fusion-activated Ca2+-entry”. Subse-
quently, they found that FACE is mediated via activation of P2X4
receptors expressed on the limiting membranes of LBs (Miklavc
et al., 2011). Upon exocytosis of LBs, the P2X4 receptor is read-
ily part of the apical membrane as soon as membrane fusion is
completed (Miklavc et al., 2009). Activation of P2X4 in the pres-
ence of extracellular ATP then results in a transient, non-selective,
inward-rectifying, cation current at the site of the fused vesicle
(Miklavc et al., 2011; Thompson et al., 2013) (Figure 1). The rel-
atively high Ca2+ permeability of P2X4 receptors (North, 2002)
causes a local, transient rise of [Ca2+]c around the fused vesicle
which promotes fusion pore expansion (Miklavc et al., 2011). In
ATII cells, vesicle content (i.e., surfactant) release is tightly reg-
ulated via Ca2+-dependent fusion pore expansion (Haller et al.,
2001) and it has been demonstrated that FACE via P2X4 recep-
tors on LBs directly facilitates surfactant release in the alveolus
(Miklavc et al., 2011).
Ca2+ channels localized in the membranes of the secretory
vesicles that respond to changes in the membrane potential or
extracellular agonists upon fusion are ideally suited for generat-
ing a localized rise in Ca2+ and selectively affect the individual
fused vesicle. Yet, so far such mechanisms have only been known
in invertebrates (Smith et al., 2000; Yao et al., 2009; Miklavc and
Frick, 2011) and P2X4 receptors on LBs resemble the ﬁrst analog
mechanism in mammals. It will be interesting to see whether a
similar role for P2X receptors is present in other secretory cells.
Similar to LBs in ATII cells, many different cell types harbor secre-
tory lysosomesor lysosome-relatedorganelles to store for secretory
products that are released via exocytosis of these organelles
(Dell’Angelica et al., 2000; Blott and Grifﬁths, 2002; Luzio et al.,
2007). Many of these contain rather bulky, macromolecular vesi-
cle contents and release is modulated via the exocytic post-fusion
phase (Thorn, 2009). In addition, it is well established that P2X
receptors, in particular P2X4, are predominantly located within
lysosomal compartments and inserted into the cell surface upon
exocytosis (Qureshi et al., 2007; Toyomitsu et al., 2012).
VESICULAR P2X4 RECEPTORS FACILITATE “ACTIVATION” OF
SURFACTANT
Following release into the alveolar hypophase surfactant main-
tains its compact organization, constituting lamellar body-like
particles (LBPs; Haller et al., 2004). To gain its vital function of
reducing the surface tension within alveoli, it needs to be inserted
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into the air–liquid interface. Freshly released LBPs disintegrate
when they contact an air–liquid interface, leading to instantaneous
spreading and insertion of surfactant material at this interface
(Dietl and Haller, 2005). Thompson et al. (2013) demonstrated
that, in addition to facilitating fusion pore dilation, FACE via
P2X4 also drives ﬂuid resorption from the alveolar lumen. The
P2X4 mediated inward-rectifying cation current on the apical
side results in vectorial ion transport across ATII cells, which
in turn promotes apical to basolateral ﬂuid transport (Thomp-
son et al., 2013) (Figure 1). FACE-dependent transepithelial ﬂuid
resorption is a rather transient process which requires the pres-
ence of luminal ATP or other P2X4 agonists and hence it is
unlikely that it is a major contributor to regulation of alveolar
liquid homeostasis under physiological conditions (Folkesson and
Matthay, 2006). However, it has been suggested that this local-
ized alveolar ﬂuid resorption results in temporary thinning of the
alveolar hypophase which in turn promotes contact between LBPs
and the interphase and facilitates adsorption of newly released
surfactant into the air–liquid interface (Thompson et al., 2013).
Hence, activation of P2X4 and FACE (which in order to embrace
the true nature of FACE should now be referred to as “fusion-
activated cation entry”) facilitates surfactant release via fusion
pore opening and contributes to “activation” or “functionalising”
of surfactant. Such a temporal and local coordination of surfactant
secretion and reduction of alveolar lining ﬂuid could constitute a
powerful mechanism for ﬁne-tuning surfactant replenishment –
the integrators being vesicular P2X4 receptors and extracellular
ATP.
ATP AS INTEGRATOR FOR SURFACTANT SECRETION AND
“ACTIVATION”
It is intriguing that extracellular ATP plays multiple functions for
surfactant secretion in the alveolus. Apart from P2X4 receptors,
ATII cells also express P2Y2 receptors (Garcia-Verdugo et al., 2008;
Burnstock et al., 2012) and activation thereof is one of the most
potent stimuli for LB exocytosis and surfactant secretion (Rice
and Singleton, 1987; Frick et al., 2001; Andreeva et al., 2007; Dietl
et al., 2010). Hence, ATP is integrating the entire secretion process
from stimulating LB exocytosis to facilitating surfactant release
and “activating” surfactant during the post-fusion phase.
Despite this importance of ATP for lung function, the origins
of ATP in the alveoli are still elusive. It has been reported that
ATP is present in the pulmonary hypophase (Patel et al., 2005),
however, the estimated concentration under resting conditions is
in the low nM range (Bove et al., 2010), well below the EC50 values
for P2X4 activation (North, 2002) or P2Y2 activation (Lazarowski
et al., 1995; Brunschweiger and Muller, 2006).
Cell stretch during deep inﬂation is considered the most
potent if not only physiologically relevant stimulus for surfac-
tant secretion (Wirtz and Dobbs, 2000; Dietl et al., 2004, 2010;
Frick et al., 2004) and stretch-induced ATP release from alveo-
lar epithelial cells (Patel et al., 2005; Mishra et al., 2011) could
represent a key regulatory element (Dietl et al., 2010). Sev-
eral possible pathways for ATP release have been described in
the respiratory epithelia. ATP can either be released into the
hypophase via regulated exocytosis from secretory cells (Kreda
et al., 2010; Okada et al., 2011), or in a conductive way via
pannexin hemichannels (Ransford et al., 2009; Seminario-Vidal
et al., 2011) or P2X7 receptors (Mishra et al., 2011). In partic-
ular, local ATP release within individual alveoli may provide
an ideal mechanism to gradually adapt local surfactant secre-
tion to local demands. The alveolar epithelium consists of only
two cell types; besides surfactant secreting ATII cells, ﬂat alve-
olar type I (ATI) cells cover most of the alveolar surface. In
contrast to primary ATII cells that only express P2X4 receptors
(Miklavc et al., 2011) ATI cells express P2X4 and P2X7 receptors
(Weinhold et al., 2010; Burnstock et al., 2012). P2X7 knock-out
mice fail to increase surfactant secretion in response to hyper-
ventilation and substantial evidence suggests that ATP release
via P2X7 receptors on ATI cells maintains alveolar surfactant
homeostasis in response to increased alveolar distension by stim-
ulating P2Y2 receptors on ATII cells (Mishra et al., 2011) and, in
light of our recent ﬁndings, possible activation of P2X4 (Miklavc
et al., 2011; Thompson et al., 2013). In addition to responding
to mechanical distension of alveoli, alveolar epithelial cells also
respond to increased tension forces at the air–liquid interphase
with exocytic release of ATP (e.g., upon local depletion of sur-
factant or when coming in close proximity to the air–liquid
interphase following a decrease in alveolar hypophase height;
Ramsingh et al., 2011).
Whether ATII cells also release ATP, to act in an autocrine feed-
back loop, is still unknown. Many secretory vesicles, including
lysosome-related organelles, have been found to contain signiﬁ-
cant amounts of ATP (Bodin and Burnstock, 2001; Praetorius and
Leipziger, 2009; Lazarowski et al., 2011) and it has been reported
that ATP is released fromATII-like A549 cells, likely via exocytosis
(Tatur et al., 2008; Ramsingh et al., 2011). It is tempting to spec-
ulate that LBs contain ATP and hence provide the ligand for the
P2X4 receptors themselves. In such a scenario, the high degree of
pH sensitivity of this receptor (Clarke et al., 2000; Zsembery et al.,
2003; Coddou et al., 2011) could prevent intravesicular activation
of the receptor in the presence of vesicular ATP (pH of LB is<6.1;
Chander et al., 1986).
Also, under pathophysiological conditions resulting frommany
chronic lung diseases, release of purine nucleotides from respira-
tory epithelia is signiﬁcantly increased (Adriaensen and Timmer-
mans, 2004; Lommatzsch et al., 2010). It has been demonstrated
that trauma-induced damage of the alveolus leads to substantial
ATP release and that extracellularATP is a key player to rescue alve-
olar function following damage, including regulation of surfactant
secretion (Riteau et al., 2010; Belete et al., 2011). In addition, sev-
eral studies have demonstrated up-regulation of P2X receptors in
various cell types duringpathological conditions including inﬂam-
mation, tumor growth, and injury (Burnstock and Kennedy,
2011) and it has been hypothesized that chronic extracellular
ATP may be responsible (Geisler et al., 2013). Such a mecha-
nism could be particularly relevant in the lung, and P2X receptors
may play an even greater role in many pathological conditions
with chronically increased extracellularATP levels. Initial evidence
came from studies indicating that smoke-induced lung inﬂamma-
tion leads to increased levels of ATP in broncho-alveolar ﬂuid
and up-regulation of P2X7 expression (Lommatzsch et al., 2010;
Lucattelli et al., 2011). A similar role for P2X4 receptors under
pathophysiological conditions is still to be conﬁrmed. However,
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it is becoming increasingly evident that purinergic signaling is tak-
ing center stage in regulating secretion of pulmonary surfactant
and adapting it to local demands under physiological and diseased
conditions. P2X4 receptors on LBs provide an ideal mechanism
for ﬁne-tuning surfactant secretion via ATP levels in the alveolar
hypophase.
Despite recent advances in our understanding how puriner-
gic signaling in the alveolus, in particular activation of vesicular
P2X4 receptors, modulates LB exocytosis, surfactant secretion and
activation of released surfactant, several important questions still
remain to be answered: What is the physiological relevance of
such a complex regulatory mechanism? What are the sources of
ATP under physiological and more importantly pathophysiolog-
ical conditions? And – extending the scope from the lung – is
purinergic signaling a general mechanism for secretion of large,
macromolecular vesicle contents or is it unique to LB exocytosis
and surfactant secretion? The answers to these questions warrant
further research and certainly promise an increased understanding
of the role of P2X receptors in regulating exocytosis and cellular
secretion.
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